-β-:,退

Sruthi Laakshmi Mugundhan1, Purushothaman Balasubramaniyan1, Damodharan Narayanasamy1

  • 1Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, India.

PubMed
概括

这项研究开发了用于神经退行性疾病的快速溶解的库尔库明-β-环氧氨酸纳入复合物的口服片. 优化的配方与粉糖酸盐和Neusilin® ULF2证明了黄素溶解和分解时间的增强.